Single-Blind, Multicenter, Placebo Controlled, Parallel Study to Assess the Safety and Efficacy of Intralesional Interferon α-2b for Minimally Invasive Treatment for Peyronie’s Disease

No AccessJournal of UrologyInvestigative urology1 Jul 2006Single-Blind, Multicenter, Placebo Controlled, Parallel Study to Assess the Safety and Efficacy of Intralesional Interferon α-2b for Minimally Invasive Treatment for Peyronie’s Diseaseis accompanied byNonsurgical Management of Peyronie’s Disease—Are We Making Any Progress? Wayne J.G. Hellstrom, Muammer Kendirci, Richard Matern, Yolanda Cockerham, Leann Myers, Suresh C. Sikka, Dennis...